The high frequency of IDH1 and IDH2 (collectively referred to as IDH) mutations in benign cartilage tumours indicates that these mutations occur early in tumourigenesis, suggesting that IDH mutations have an important driver role in the formation of cartilage tumours. This evidence concerns the gene IDH1 and chondrogenic neoplasm.